FAGRON SERVICES NORTHERN EUROPE SP Z O O
Location
małopolskie
Founded
2018-08-20
Website
Risk Signals
225 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Food Preparations, Not Elsewhere Classified, Pharmaceutical Preparations, Perfumes, Cosmetics, and Other Toilet Preparations, Adhesives and Sealants, Explosives, Chemicals and Chemical Preparations, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about FAGRON SERVICES NORTHERN EUROPE SP Z O O
Live alerts from global media, monitored by Business Radar

2025-04-18 (levif.be)
Essentials - Trends -Tendances
Turnover increased by 14.1% to 238.7 million euros, thanks to the pursuit of strong organic sales growth of 12.6%. This figure is slightly higher than the average analyst forecasts, which was 230.4 million euros.
Read more
2025-01-07 (lecho.be)
Higher rates drag Wall Street down
Fagron starts the year with new acquisitions. WDP and Montea wanted. NVIDIA impacted by profit taking.
Read more2024-10-22 (beleggersbelangen.nl)
Fagron | Pharmaceutical company maintains growth rate
Fagron once again achieved a turnover figure in the third quarter that exceeded expectations. Once again it was insufficient for a price breakout.
Read more2024-10-12 (deaandeelhouder.nl)
Fagron is back on track
Fagron: back on the right track Good turnover growth after 9 months The US remains an important growth engine Margin improvement expected this year Fagron yesterday provided an update on the third quarter.
Read more2024-10-12 (beursgorilla.nl)
Stock market view: Kepler Cheuvreux increases Fagron price target slightly
(ABM FN-Dow Jones) Kepler Cheuvreux increased the price target for Fagron from 19.25 to 19.50 euros, while maintaining the Hold recommendation. This emerged from a report from the investment bank on Friday. The third quarter showed strong organic growth of ...
Read more2024-10-10 (iex.nl)
Stock exchange view: impressive growth again at Fagron
Fagron once again showed impressive growth in the past quarter. Degroof Petercam concluded this on Thursday in response to the figures from the master preparer.
Read more2024-10-10 (thefinancialanalyst.net)
Fagron Reports 12.1% Revenue Growth in Q3 2024, Boosting Market Confidence
Fagron, a global leader in the pharmaceutical compounding sector, reported a robust third quarter for 2024, showcasing a revenue growth of 12.1%.
Read more
2024-10-10 (iex.nl)
Stock exchange view: Fagron exceeds expectations
Fagron exceeded turnover expectations in the third quarter. Kepler Cheuvreux analysts concluded this in a report on Thursday.
Read more
2024-10-10 (iex.nl)
Fagron turnover growth continues
Fagron recorded higher turnover in the third quarter of this year and maintained the outlook for the whole of 2024. This was evident from figures from the pharmaceutical compounder on Thursday.
Read more
2024-10-08 (deaandeelhouder.nl)
Stock market view: higher Fagron turnover expected
Fagron is likely to have achieved higher turnover in the third quarter of 2024 compared to the same period a year earlier. This was evident from the analyst consensus that was compiled in the run-up to the figures of the pharmaceutical company.
Read more2024-10-04 (iex.nl)
Akzo and financials give AEX a narrow daily profit and a weekly loss, but luckily we still have Shell
The AEX ended narrowly higher after a better-than-expected American jobs report. Nerves about the Middle East continue. And these are the most striking risers and fallers of last week.
Read more
2024-10-01 (beleggersbelangen.nl)
Editorial tips Johan Brinkman | Difficult third quarter
In a persistently positive stock climate, my tips continued to have difficulty paying off in the third quarter.
Read more